In addition, compared with VEGF-A inhibitors alone, metformin combined with VEGF-A inhibitors is more effective in inhibiting tumor growth [55], indicating that the combined application of metformin be a promising route to increase its antitumoral efficacy. This evidence concerns the gene VEGFA and neoplasm.